Prealbumin-bilirubin score provides more accurate prognostic predictions for long-term survival after hepatectomy for hepatocellular carcinoma

A multicenter study developed and validated the prealbumin-bilirubin (preALBI) score as an alternative to the widely used albumin-bilirubin (ALBI) score for predicting long-term survival after hepatectomy for hepatocellular carcinoma (HCC). The preALBI score, incorporating serum prealbumin and bilirubin levels, showed superior performance in predicting survival compared to the ALBI score and Child-Pugh grade. Leveraging the stability of prealbumin, the preALBI score represents a promising tool for better patient stratification and more accurate prognostic predictions in HCC patients undergoing hepatectomy.